Doximity
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 months.
- Recent price momentum is -13.7% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 3.9% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 39.9x | Better than 14% |
| Forward P/E | 43.4x | Better than 9% |
| Price / Sales | 9.0x | Better than 11% |
| P/E vs own 5-yr range | 47th pctl | Better than 62% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 15.5% | Better than 76% |
| Net income CAGR (3Y) | 20.2% | Better than 73% |
| Free cash flow CAGR (3Y) | 22.3% | Better than 67% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 89.1% | Better than 96% |
| Operating margin | 33.3% | Better than 92% |
| Net margin | 30.4% | Better than 91% |
| Return on equity | 19.3% | Better than 77% |
| Return on invested capital | 16.3% | Better than 84% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 13.4% | Better than 93% |
| 6-month return | 44.1% | Better than 94% |
| 12-month return (ex latest month) | -33.8% | Better than 7% |
| Distance below 52-week high | 44.6% | Better than 24% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 6.1x | Better than 89% |
| Debt to assets | 0.9% | Better than 93% |
| Free cash flow / net income | 161.9% | Better than 69% |
Analyst View D
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 40.0% | Better than 21% |
| Upside to average target | 4.0% | Better than 7% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 29.61
- Open
- 29.32
- Day range
- 28.55 - 29.86
- Avg price
- 28.92
- Volume
- 2.38M
- Turnover
- 68.85M
- Turnover ratei
- 1.92%
- Volume ratioi
- 1.14
- Amplitudei
- 4.42%
- 52-week rangei
- 17.15 - 51.85
Valuation
- P/Ei
- 29.32
- P/E (TTM)i
- 39.90
- P/Bi
- 5.52
- EPSi
- 0.98
- Book value / shi
- 5.20
- Net profit
- 174.84M
- Net assets
- 928.44M
Share structure
- Market cap
- 5.13B
- Float capi
- 3.56B
- Shares out
- 178.41M
- Float sharesi
- 123.77M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2021-06-24
44.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+22.00M net over the window
Short interest
- Shares short
- 6.95M
- % of floati
- 3.90%
- Days to coveri
- 2.68
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Doximity (DOCS)?
Doximity last traded at 28.73. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Doximity's market cap?
About 5.13B.
What is the P/E ratio of Doximity?
The trailing twelve-month P/E is 39.90, below its own 5-year average of 48.80 — in the middle of its historical range (47.45% percentile). See the Valuation tab for the full history.
Does Doximity pay a dividend?
Doximity does not currently pay a regular dividend.
Is Doximity a buy according to analysts?
The consensus of 10 analysts is a Hold rating, with an average 12-month price target of 29.88, which implies 4.0% upside from the current price. This is not investment advice.
What is Doximity's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Doximity a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 20:01:27 · For reference only, not investment advice and not tailored to your situation.
Doximity discussion 0 comments